To keep up with advances in artificial intelligence and machine learning in the health-care sector, US FDA is working to develop a draft guidance that would help sponsors gain clarity on what the agency expects from them.
FDA Commissioner Scott Gottlieb issued a statement on April 2 espousing the potential of AI to change the face of health care. He timed it with the release of a
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?